Details for 2018150455
Up to date per 02.04.2026
Actions
Details for 2018150455
Granted/Registered
European Patent
27.02.2019 A
22.09.2021 B1
24.08.2017
EP
17187684
A61K 39/00 20060101AFI20180508BHEP
Owner
Isofol Medical ABBiotech Center Arvid Wallgrens Backe 20 413 46 GöteborgSE
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
LINDBERG, Per LennartMellangatan 7 413 01 GöteborgSE
SUNDÉN, Gunnel ElisabetMellangatan 7 413 01 GöteborgSE
GUSTAVSSON, BengtBergsbogatan 29 426 79 Västra FrölundaSE
VEDIN, AndersPrästgårdsgatan 62 412 71 GöteborgSE
Information about Fees